Back
 JBM  Vol.4 No.11 , November 2016
Comparative Study of Urosepsis-Associated Escherichia coli in Tertiary Care University Hospital in the Central Region of Japan from 2008 to 2011
Abstract: Escherichia coli infection is important cause of morbidity and mortality. Urosepsis is most commonly caused by Escherichia coli. It is generally reported to have low mortality rates and favorable outcomes compared with sepsis induced in other organ/ system or tissues. This study was conducted to find out the clinical characteristics of urosepsis-associated Escherichia coli isolates at tertiary care university hospital in the central region of Japan from 2008 to 2011. Escherichia coli was identified by standard laboratory procedure. Antimicrobial susceptibility testing was performed by micro dilution assay according to CLSI recommendation. We analyzed the relationship between medical records appended to clinical species and bacterial data by using a statistical method. Of one hundred five Escherichia coli, fifty-three were from urosepsis and fifty-two were from other disease. The ratio of male to female from urosepsis tended to be lower than that from others. Forty-two isolates were from outpatient and sixty-three were from inpatient. The ratio of inpatient to outpatient from urosepsis was significant lower than that from others. With respect to age, the numbers of elder patients were higher than those of others. Most of the Escherichia coli isolates were from the emergency room followed by urology, and general medicine. The ratio of urosepsis to no urosepsis at urology department was significant higher than that at other departments. With respect to antimicrobial susceptible pattern, the ratio of urosepsis to no urosepsis about only aztreonam resistant was significant higher than that about other antibiotics. We need enough attention to be paid to urosepsis, especially female and elder patients.
Cite this paper: Minami, M. , Wakiyama, N. , Ohhashi, M. , Wakimoto, Y. and Ohta, M. (2016) Comparative Study of Urosepsis-Associated Escherichia coli in Tertiary Care University Hospital in the Central Region of Japan from 2008 to 2011. Journal of Biosciences and Medicines, 4, 18-23. doi: 10.4236/jbm.2016.411003.
References

[1]   Wagenlehner, F.M., Lichtenstern, C., Rolfes, C., Mayer, K., Uhle, F., Weidner, W., et al. (2013) Diagnosis and Management for Urosepsis. International Journal of Urology, 20, 963-970.
http://dx.doi.org/10.1111/iju.12200

[2]   Brun-Buisson, C. (2000) The Epidemiology of the Systemic Inflammatory Response. Intensive Care Medicine, 26, S64-S74.
http://dx.doi.org/10.1007/s001340051121

[3]   Hotchkiss, R.S. and Karl, I.E. (2003) The Pathophysiology and Treatment of Sepsis. The New England Journal of Medicine, 348, 138-150.
http://dx.doi.org/10.1056/NEJMra021333

[4]   Nicolle, L.E. (1997) Asymptomatic Bacteriuria in the Elderly. Infectious Disease Clinics of North America, 11, 647-662.
http://dx.doi.org/10.1016/S0891-5520(05)70378-0

[5]   DasGupta, R., Sullivan, R., French, G. and O’Brien, T. (2009) Evidence-Based Prescription of Antibiotics in Urology: A 5-Year Review of Microbiology. BJU International, 104, 760-764.
http://dx.doi.org/10.1111/j.1464-410x.2009.08779.x

[6]   Saravu, K., Prasad, M., Eshwara,V.K. and Mukhopadhyay. C. (2015) Clinico-Microbio-logical Profile and Outcomes of Nosocomial Sepsis in an Indian Tertiary Care Hospital—A Prospective Cohort Study. Pathogens and Global Health, 109, 228-235.
http://dx.doi.org/10.1179/2047773215Y.0000000026

[7]   Clinical and Laboratory Standards Institute (2014) Performance Standards for Antimicrobial Susceptibility Testing: 24st Information Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.

[8]   Tandogdu, Z., Bartoletti, R., Cai, T., Çek, M., Grabe, M., Kulchavenya, E., et al. (2016) Antimicrobial Resistance in Urosepsis: Outcomes from the Multinational, Multicenter Global Prevalence of Infections in Urology (GPIU) Study 2003-2013. World Journal of Urology, 34, 1193-1200.
http://dx.doi.org/10.1007/s00345-015-1722-1

[9]   Qiang, X.H., Yu,T.O., Li, Y.N. and Zhou, L.X. (2016) Prognosis Risk of Urosepsis in Critical Care Medicine: A Prospective Observational Study. BioMed Research International, 2016, 9028924.
http://dx.doi.org/10.1155/2016/9028924

[10]   Bjerklund, Johansen,T.E., Cek, M., Naber, K., Stratchounski, L., Svendsen, M.V., Tenke, P., PEP and PEAP Study Investigators; European Society of Infections in Urology (2007) Prevalence of Hospital-Acquired Urinary Tract Infections in Urology Departments. European Urology, 51, 1100-1111.
http://dx.doi.org/10.1016/j.eururo.2006.08.012

[11]   Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al., Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup (2013) Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Critical Care Medicine, 41, 580-637.
http://dx.doi.org/10.1097/CCM.0b013e31827e83af

 
 
Top